Komezol (Omeprazole)

Omeprazole works by irreversibly binding to the H+/K+ ATPase enzyme, also known as the gastric proton pump, on the surface of stomach parietal cells. This inhibition blocks the final step of acid secretion, leading to a sustained reduction in gastric acidity and allowing damaged tissues to heal.

The appropriate dose of Komezol is determined by a qualified healthcare professional based on the specific condition being treated, patient age, renal and hepatic function, and other individual factors. Patients should follow the prescribing clinician’s instructions and not adjust the dose without medical advice.

Omeprazole is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are no well‑controlled studies in pregnant women. It may be used during pregnancy only if the potential benefit justifies any potential risk. Small amounts are excreted in breast milk; breastfeeding mothers should discuss use with their physician.

To order Komezol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team will then provide pricing, availability, shipping details and any necessary import documentation.

Komezol (omeprazole) belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, omeprazole has a well‑established safety profile and is widely available, though individual response and drug‑interaction potential may vary.

Komezol should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Komezol is taken orally, usually as a tablet swallowed whole with a glass of water. It is generally recommended to take the medication before a meal, but patients should follow the specific timing instructions provided by their healthcare provider.

Serious risks, though uncommon, include Clostridioides difficile‑associated diarrhea, acute interstitial nephritis, and an increased risk of bone fractures with long‑term use. Patients should report persistent diarrhea, unexplained kidney problems, or severe bone pain to their physician promptly.

Komezol is contraindicated in patients with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for individuals with severe liver disease, and it should be avoided in patients taking medications that require an acidic environment for absorption unless supervised by a clinician.